The herpes zoster vaccine (Zostavax) has been shown to decrease the risk of shingles by almost 70 percent. The vaccine has been shown to be effective and is approved by the Food and Drug Administration for adults age 50 and older and is recommended for all adults 60 and older regardless of whether they have had shingles in the past.

Nov. 13, 2012